Rare lephants
Screener

Fulcrum Therapeutics, Inc.

FULC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Sep 16, 2024 SC 13G/A
8-K Sep 12, 2024 8-K
SC 13G/A Aug 23, 2024 SC 13G/A
4 Aug 23, 2024
8-K Aug 22, 2024 8-K
S-8 Jul 31, 2024 S-8
10-Q Jul 31, 2024 10-Q
8-K Jul 31, 2024 8-K
4 Jul 8, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
4 Jun 18, 2024 4
3 Jun 18, 2024 3
8-K Jun 17, 2024 8-K
10-Q May 13, 2024 10-Q
8-K May 13, 2024 8-K
4 May 9, 2024 4
EFFECT Apr 25, 2024
CORRESP Apr 24, 2024
ARS Apr 19, 2024 ARS
← Newer Page 6 of 21 · 513 filings Older →